Tectonic Therapeutic (TECX) Depreciation and Depletion (2023 - 2024)

Tectonic Therapeutic's (TECX) quarterly Depreciation and Depletion came in at $281000.0 in Q3 2024, up 10.2% year-on-year from $255000.0 in Q4 2023, and up 6.44% on a QoQ basis from $264000.0 in Q2 2024.

Tectonic Therapeutic (TECX) Depreciation and Depletion (2023 - 2024) Analysis & Trends

Tectonic Therapeutic (TECX) has 2 years of Depreciation and Depletion data on file, last reported at $281000.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 39.39 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Tectonic Therapeutic 595.23 Mn 595.23 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 281,000.00
Sep 30, 2024 281,000.00
Jun 30, 2024 264,000.00
Jun 30, 2024 264,000.00
Sep 30, 2023 255,000.00
Sep 30, 2023 255,000.00
Jun 30, 2023 200,000.00
Jun 30, 2023 200,000.00